Semaglutide, a new and effective drug for the treatment of type 2 diabetes, is about to come out
Semaglutide, a new and effective drug for the treatment of type 2 diabetes, is about to come out December 13, 2016 Source: Healio/fish According to Novo Nordisk, a new drug for the treatment of type 2 diabetes, the glucagon-like peptide-1 (GLP-1) analog Semaglutide (Somaglutide), has been administered once a week. The FDA filed a new drug application. Through oral hypoglycemic agents such as DPP-IV inhibitor sitagliptin (Januvia, Merck), GLP-1 receptor agonist Exenatide (Byetta, AstraZeneca) and once daily insulin glargine U100 and comfort Compared with the agent, Semaglutide can achieve control and maintenance of blood sugar levels, and shows better clinical treatment. In addition, Semaglutide can also induce weight loss by reducing appetite and reduce cardiovascular risk. The most common side effects of Semaglutide are nausea, vomiting, diarrhea, abdominal pain and constipation. “For adults with type 2 diabetes, achieving glycemic control, weight loss and reducing the risk of cardiovascular events remains a major challenge,†said Novo Nordisk Chief Scientific Officer, Executive Vice President Mads Krogsgaards Thomsen in press release Said at the meeting. “We are pleased to see that Semaglutide, once a week, is potentially beneficial in treating adult type 2 diabetes.†In addition, Novo Nordisk has also filed an application with Semaglutide to the European Medicines Agency. Eas anti-theft antenna is mainly suitable for large supermarkets, shopping malls, bookstores, audio stores with Security hard tags, rf soft label, AM lable,Pin and Lanyard, eas detacher, Hook Lock,EAS Self Alarm Tag, EAS Safer Box,etc. ZHEJIANG BOSHINE ELECTRONIC SECURITY CO.,LTD , https://www.cnboshine.com